David Spellmeyer

David Spellmeyer

Consultant / Advisor at ShangPharma Innovation, Inc.

Health Technology
Consumer Services
Commercial Services

Profile

David C.
Spellmeyer
is currently an Advisor at Circle Pharma, Inc. and an Executive in Residence at ShangPharma Innovation, Inc. He previously worked as a Director & Vice President at CombiChem, Inc. from 1997 to 1999, as an Executive Director at DuPont Pharmaceuticals Co. from 1999 to 2001, as a Principal Scientist at Chiron Corp.
and International Business Machines Corp., and as the Chief Scientific Officer & VP-Drug Discovery at Signature BioScience, Inc. from 2001 to 2002.
From 2006 to 2015, he served as the Chief Technology Officer at Nodality, Inc. Dr. Spellmeyer holds a doctorate degree from the University of California, Los Angeles, and a doctorate degree from The University of California, San Francisco.
He also holds an undergraduate degree from Purdue University.

David Spellmeyer active positions

CompaniesPositionStart
Consultant / Advisor 2017-04-30
Consultant / Advisor 2017-09-30
All active positions of David Spellmeyer

Former positions of David Spellmeyer

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 2015-04-30
Chief Tech/Sci/R&D Officer 2002-11-30
Director/Board Member 2001-03-31
Director/Board Member 1999-11-30
Corporate Officer/Principal -
See the detail of David Spellmeyer's experience

Training of David Spellmeyer

University of California, Los Angeles Doctorate Degree
The University of California, San Francisco Doctorate Degree
Purdue University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Spellmeyer's experience

Connections

100 +

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
IBM

Technology Services

Private companies7

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Finance

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. David Spellmeyer